Clinical trial
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating…
NCT00003173 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003173 |
|---|---|
| Title | High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors |
| Official title | High-Dose Thiotepa With Autologous Stem Cell Rescue in Patients With Malignancies Refractory to Conventional Chemotherapy |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Retinoblastoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, thiotepa, autologous bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 36 |
| Start date | Sep 1, 1997 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | Apr 23, 2003 |
| Last update posted | Mar 7, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: